Search - tctmd.com

Displaying 961 - 980 of 4251

Sort: Relevancy | Date

Presentation TCT 2015

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Presenter: John D. Carroll, Ioanna Kosmidou, Danny Dvir

October 15, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Susheel Kodali

October 15, 2015

Presentation TCT 2015

Master Class: Lessons Learned After 2000 Percutaneous EVAR (PEVAR) Procedures

Presenter: Clifford J. Buckley, Zvonimir Krajcer

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Ronald M. Lazar

October 15, 2015

Presentation TCT 2015

Proposed Mechanisms for Proximal Neck Enlargement After EVAR: Can Devices Without Continuous Outward Force (Nellix vs Endurant) Make a Difference?

Presenter: Clifford J. Buckley, Zvonimir Krajcer, Christopher K. Zarins

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

Presenter: John D. Carroll, Ioanna Kosmidou, Howard C. Herrmann

October 15, 2015

Presentation TCT 2015

Status Report on Endovascular Aneurysm Sealing (EVAS) With Nellix: Big Promises and a Few Unknowns

Presenter: Clifford J. Buckley, Zvonimir Krajcer

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

Is AAA Incidence on the Decline in the United States, Thereby Limiting the Value of Screening?

Presenter: Clifford J. Buckley, Zvonimir Krajcer, Christopher K. Zarins

October 15, 2015

Presentation TCT 2015

Case 4: Aortic Paravalvular Leak Closure After TAVR

Presenter: Chet Rihal, Peter M. Pollak

October 15, 2015

Presentation TCT 2015

Assessing Postdevice Paravalvular Aortic Regurgitation

Presenter: Jeroen J. Bax, Paul A. Grayburn, Rebecca T. Hahn

October 15, 2015

Presentation TCT 2015

Case 3: Aortic Paravalvular Leak Closure Surgical Valve

Presenter: Chet Rihal, Robert Kumar

October 15, 2015

Presentation TCT 2015

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Presenter: Steven R. Bailey, Patrick W. Serruys, Kreton Mavromatis

October 15, 2015

Presentation TCT 2015

Low-Flow, Low-Gradient Aortic Stenosis: How to Diagnosis, and Should We Treat?

Presenter: Jeroen J. Bax, Paul A. Grayburn, Philippe Pibarot

October 15, 2015

Presentation TCT 2015

TCT 107: The DISCOVER Registry One-Year Outcomes of a Fully Repositionable and Retrievable Nonmetallic Transcatheter Aortic Valve in a Real-World Population

Presenter: Steven R. Bailey, Patrick W. Serruys, Federico De Marco

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Industry News

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

October 15, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

Presentation TCT 2015

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

Presenter: Howard C. Herrmann

October 15, 2015

Advertisement

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Master Class: Lessons Learned After 2000 Percutaneous EVAR (PEVAR) Procedures

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

Proposed Mechanisms for Proximal Neck Enlargement After EVAR: Can Devices Without Continuous Outward Force (Nellix vs Endurant) Make a Difference?

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

Status Report on Endovascular Aneurysm Sealing (EVAS) With Nellix: Big Promises and a Few Unknowns

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Is AAA Incidence on the Decline in the United States, Thereby Limiting the Value of Screening?

Case 4: Aortic Paravalvular Leak Closure After TAVR

Assessing Postdevice Paravalvular Aortic Regurgitation

Case 3: Aortic Paravalvular Leak Closure Surgical Valve

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Low-Flow, Low-Gradient Aortic Stenosis: How to Diagnosis, and Should We Treat?

TCT 107: The DISCOVER Registry One-Year Outcomes of a Fully Repositionable and Retrievable Nonmetallic Transcatheter Aortic Valve in a Real-World Population

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content